dr. lee on the aramis trial in m0crpc
Published 5 years ago • 89 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:36
dr. lee on inclusion criteria of the aramis, spartan, and prosper trials in m0crpc
-
2:11
dr. lee on the role of darolutamide in m0crpc
-
0:55
dr. lee on choosing among antiandrogens in nonmetastatic crpc
-
1:27
dr. scholz on significance of aramis trial in crpc
-
2:35
the aramis trial in m0 crpc
-
3:51
aramis trial
-
2:47
dr. lee highlights key takeaways from spartan trial in m0crpc
-
5:12
darolutamide for nmcrpc: results of the aramis trial
-
12:08
new fda approval: darolutamide for hormone-sensitive disease | mark scholz, md | pcri
-
14:05
lutetium 177 psma - problems with the vision trial
-
4:35
is prostate cancer fatal? | ask a prostate expert, mark scholz, md
-
2:32
dr. saad on the spartan trial in m0crpc
-
1:05
dr. tan discusses the fda approval of darolutamide in m0crpc
-
3:06
enzalutamide in the context of nonmetastatic crpc
-
2:00
dr. shore on the tolerability of darolutamide in nonmetastatic crpc
-
2:46
aramis: darolutamide in patients with nmcrpc
-
2:14
dr. tagawa discusses darolutamide in crpc
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
25:49
asco 2020 prostate cancer highlights
-
1:13
dr. yu on the role of pet imaging in prostate cancer
-
1:00
dr. parker on the results of the radicals-rt trial in prostate cancer
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer